Hamps Bio Ltd.BSE: HAMPS

Unaudited Financial Result For Half Year Ended 30.09.2026

· Issued by Hamps Bio Ltd. via BSE India

Filed with BSE · · 16 pages · English

Summary by 6ix AI

The results include both standalone and consolidated financial statements, along with a limited review report. The financial results reflect the company's operations in the pharmaceutical and freeze-dried products sectors. The report indicates that the company has fully utilized the proceeds from its Initial Public Offering for specified purposes.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/unaudited-financial-result-for-half-year-ended-30.09.2026

1. Considered and approved the Unaudited Standalone and consolidated Financial Results along with Limited review report for the half year ended 30.09.2026 and the same is attached herewith. The Board Meeting commenced at 4:00 P.M (IST) and concluded at 7:00 P.M. (IST). You are kindly requested to take the above on your record and update the same. Ravi Baheti Company Secretary Enclosure: As above

Hamps Bio Ltd. on 6ix

Earlier from Hamps Bio

All Hamps Bio news releases